New test could sharply reduce risky, costly lung cancer biopsies
Press Release: May 18, 2015 | Written by Lenny Bernstein – The Washington Post When a suspicious lesion shows up in the lungs on a CT scan, the first thing your doctor wants to know is whether it’s cancerous. A specialist will pass a long, thin bronchoscope into your airway in the hope of grabbing a few cells […]
Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier
Press: April 16, 2015 | Veracyte South San Francisco, Calif. — April 16, 2015 — Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta™ Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin […]
Behind the Vapor – Chasing the facts behind e-cigarette health risks
Press: October 20, 2014; written by Sara Rimer | BU Research With the public health community sharply divided over the potential benefit and harm of the popular device—and with conclusive scientific evidence in short supply—the World Health Organization (WHO) released a report in August 2014 that raised serious questions about the health impact of e-cigarettes and called […]
Researchers will study relation of environment to breast cancer
Press: October 16th 2014, written by Todd Feathers | Boston Globe Five eminent Boston researchers will officially join forces Thursday to tackle one of the most perplexing questions about breast cancer: Why do so many people with no family history of the disease get it? The researchers will examine whether common man-made chemicals are responsible […]
Veracyte to Acquire Allegro Diagnostics: Plans to Launch Lung Cancer Test
Press release: September 4th 2014 SOUTH SAN FRANCISCO, Calif., Sept. 4, 2014 /PRNewswire/ — Veracyte, a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to acquire Allegro Diagnostics Corp. based in Maynard, Mass., for $21.0 million, comprised of $7.8 million in cash and $13.2 million in Veracyte common stock. Allegro is […]
New way to determine cancer risk of chemicals found
Press Release from July 24th 2014 A new study has shown that it is possible to predict long-term cancer risk from a chemical exposure by measuring the short-term effects of that same exposure. The findings, which currently appear in the journal PLOS ONE, will make it possible to develop simpler and cheaper tests to screen chemicals […]
BUSM Researchers Identify Molecule that Could Aid Lung Cancer Detection, Treatment
Press Release: From October 28th 2013 Written by Jenny C Leary Researchers at Boston University School of Medicine (BUSM) have discovered a molecule that could help lead to the non-invasive detection of lung cancer as well as its treatment. Using RNA sequencing, the team looked at airway epithelial cells and identified a regulatory molecule that […]
BUSM Researchers Identify Novel Approach to Study COPD and Treatment Efficacy
Press Release: From April 11, 2013 Written By Jenny C Leary BUSM researchers have pinpointed a genetic signature for chronic obstructive pulmonary disease (COPD) from airway cells harvested utilizing a minimally invasive procedure. The findings provide a novel way to study COPD and could lead to new treatments and ways to monitor patient’s response to […]
Never Smoker Lung Cancer
Press Release : BU Today January 22 2013 Never Smoked. Lived Right. Died of Lung Cancer. By Rich Barlow Avrum Spira’s aunt died of lung cancer almost 20 years ago. She was a nonsmoking exercise buff in her 40s who hadn’t been exposed to any known toxins; she worked in a government office, not a […]
How gene profiling in emphysema is helping to find a cure
Press Release: BioMed Central August 31, 2012 Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States and is thought to affect almost three million people in the UK. New research published in BioMed Central’s open access journal Genome Medicine has identified genes whose activity is altered with increasing […]